{
  "Variants Include": [
    {
      "Gene": "UCHL1",
      "variants": [
        {
          "HGVS": "NM_002525.4:c.753A>G",
          "cDNA Change": {
            "transcript": "NM_002525.4",
            "ref": "A",
            "alt": "G",
            "position": "753"
          },
          "Protein Change": {
            "ref": "I",
            "alt": "V",
            "position": "251"
          },
          "Description in input context": "This variant results in the substitution of Isoleucine with Valine at position 251."
        },
        {
          "HGVS": "NM_002525.4:c.773G>A",
          "cDNA Change": {
            "transcript": "NM_002525.4",
            "ref": "G",
            "alt": "A",
            "position": "773"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "Q",
            "position": "258"
          },
          "Description in input context": "This variant results in the substitution of Arginine with Glutamine at position 258."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's Disease",
    "MONDO": "MONDO:0003373"
  },
  "Experiment Method": [
    {
      "Assay Method": "Immunoblotting (Western Blot)",
      "Material used": {
        "Material Source": "Patient Derived Material",
        "Material Name": "Postmortem Brain Tissue",
        "Description": "Western blot analysis was performed on postmortem brain tissue samples from Parkinson's disease patients."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_002525.4:c.753A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Loss of Function",
          "Result Description": "UCHL1 protein expression was significantly reduced (approximately 60%) in carriers of the NM_002525.4:c.753A>G variant."
        },
        {
          "Variant": "NM_002525.4:c.773G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Partial Loss of Function",
          "Result Description": "UCHL1 protein expression was moderately reduced (approximately 30%) in carriers of the NM_002525.4:c.773G>A variant."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Each variant was analyzed in three separate brain tissue samples."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was processed and blotted in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Brain tissue from age-matched controls without UCHL1 mutations served as positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Brain tissue from age-matched controls without UCHL1 mutations served as negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "N/A"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "N/A"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "t-test was used to compare protein expression levels."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression level within the range observed in age-matched controls.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression level more than 2 standard deviations below the mean observed in age-matched controls.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}